FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
批准号:
6116549
负责人:
M ROSENZWEIG
金额:
$12.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-01 至 2000-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Optimization of the harvesting and transduction of hematopoietic
stem cells is critical to successful stem cell gene therapy We
evaluated the utility of a novel protocol involving flt-3 and G-CSF
mobilization of peripheral blood stem cells and retroviral
transduction using hematopoietic growth factors to introduce a
reporter gene, murine CD24, into hematopoietic stem cells in nonhuman
primates Rhesus macaques were treated with flt-3 ligand (200 mg/kg)
and G-CSF (20 mg/kg) for 7 days and autologous CD34+ peripheral blood
stem cells harvested by leukapheresis CD34+ cells were transduced with
an MFG-based retroviral vector encoding murine CD24 using 4 daily
transductions with centrifugations in the presence of flt-3 ligand
(100 ng/ml), SCF (100 ng/ml) and PIXY (100 ng/ml) in serum free medium
Animals were sublethally irradiated (400 cGy) on the day of
transplantation Engraftment was monitored sequentially in the bone
marrow and blood using both multiparameter flo w cytometry and
semi-quantitative DNA PCR Our data demonstrate successful and
persistent engraftment in multiple hematopoietic lineages, including
granulocytes, monocytes and B and T lymphocytes At 46 and 117 days
post transplantation 75% and 6% of granulocytes, respectively,
expressed mCD24 antigen at the cell surface Peak in vivo levels of
genetically-modified peripheral blood lymphocytes (PBL) approached 60%
as assessed both by flow cytometry and PCR 18 days post
transplantation In addition, naive (CD45RA+ and CD62L+) CD4+ and
CD3+8+ cells were the predominant phenotype of the T cells detected at
this time Engraftment has subsequently plateaued but persisted at
between 10 and 15% of PBLs for 133 days Acytotoxic T cell response
against murine CD24 was detected in only one animal This degree of
persistent long-lived, high level gene marking of multiple
hematopoietic lineages, including naive T cells, has important
implications for the field of stem cell gene therapy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6591322
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6591288
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6591317
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6591316
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
-
批准号:6591324
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6591306
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6453762
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6453763
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6453734
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6453768
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
FLT LIGAND PERIPHERAL BLOOD STEM CELL MOBILIZATION FOR STEM CELL GENE THERAPY
-
批准号:6453770
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6453752
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:M ROSENZWEIG
-
依托单位:
IN VIVO ANALYSIS OF T CELL TURNOVER IN RHESUS MACAQUES
-
批准号:6116542
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
STEM CELL GENE THERAPY USING LONG TERM BONE MARROW CULTURE TRANSDUCTION PROTOCOL
-
批准号:6116551
-
项目类别:
-
资助金额:$12.84万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6116541
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6116550
-
项目类别:
-
资助金额:$10.61万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6116547
-
项目类别:
-
资助金额:$12.84万
-
财政年份:1999
-
负责人:M ROSENZWEIG
-
依托单位:
EXPRESSION OF BCL 2 IN SIV INFECTED THYMIC TISSUE
-
批准号:6313032
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
ESTABLISHMENT OF RHESUS BONE MARROW CHIMERAS
-
批准号:6313038
-
项目类别:
-
资助金额:$3.41万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
XENOGENEIC THYMIC TRANSPLANTATION AS AN ADJUNCT TO TREATMENT OF AIDS
-
批准号:6313022
-
项目类别:
-
资助金额:$9.62万
-
财政年份:1978
-
负责人:M ROSENZWEIG
-
依托单位:
海外基金